The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective

被引：45
作者：
Liu, Jian-Jun [1 ]
Foo, Joo Pin [2 ]
Liu, Sylvia [1 ]
Lim, Su Chi [3 ]
机构：
[1] Khoo Teck Puat Hosp, Clin Res Unit, Singapore 768828, Singapore
[2] Changi Gen Hosp, Dept Med, Singapore, Singapore
[3] Khoo Teck Puat Hosp, Ctr Diabet, Singapore 768828, Singapore
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2015年 / 108卷 / 03期
关键词：
Fibroblast growth factor 21; Diabetes; Diabetes complications; Diabetes therapy; INCREASES ENERGY-EXPENDITURE; FATTY LIVER-DISEASE; SERUM FGF21 LEVELS; INSULIN SENSITIVITY; METABOLIC SYNDROME; GLUCOSE; OBESITY; EXPRESSION; RESISTANCE; INHIBITION;
D O I：
10.1016/j.diabres.2015.02.032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Fibroblast growth factor 21 (FGF21) has been well-recognized as a metabolic hormone and a promising target for treatment of metabolic diseases. The level of endogenous FGF21 is elevated in patients with impaired glucose tolerance and progressively increased from patients with overt type 2 diabetes to those with micro-and macro-vascular complications, presumably as a compensation or response to the deterioration of metabolic imbalance. A few exploratory in vivo studies, including a recent clinical trial, showed that exogenous FGF21 mimetics targeting FGF21 signaling can attain beneficial metabolic effects not withstanding the already elevated ambient FGF21 levels. In addition, some clinically available pharmacologic agents such as fenofibrates and metformin may modulate energy and macronutrients metabolism by acting through FGF21. This review mainly focuses on the role of FGF21 in development, progression and treatment of type 2 diabetes from a clinical perspective. (c) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：382 / 389
页数：8
相关论文
共 66 条
  • [1] FGF21: The Center of a Transcriptional Nexus in Metabolic Regulation
    Adams, A. C.
    Kharitonenkov, A.
    [J]. CURRENT DIABETES REVIEWS, 2012, 8 (04) : 285 - 293
  • [2] LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
    Adams, Andrew C.
    Halstead, Carolyn A.
    Hansen, Barbara C.
    Irizarry, Armando R.
    Martin, Jennifer A.
    Myers, Sharon R.
    Reynolds, Vincent L.
    Smith, Holly W.
    Wroblewski, Victor J.
    Kharitonenkov, Alexei
    [J]. PLOS ONE, 2013, 8 (06):
  • [3] FGF21 Requires βklotho to Act In Vivo
    Adams, Andrew C.
    Cheng, Christine C.
    Coskun, Tamer
    Kharitonenkov, Alexei
    [J]. PLOS ONE, 2012, 7 (11):
  • [4] Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques
    An, So-Yeon
    Lee, Min Suk
    Yi, Sang-A
    Ha, Eun Suk
    Han, Seung Jin
    Kim, Hae Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (02) : 196 - 203
  • [5] Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
    Angelin, Bo
    Larsson, Tobias E.
    Rudling, Mats
    [J]. CELL METABOLISM, 2012, 16 (06) : 693 - 705
  • [6] Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice
    Camacho, Raul C.
    Zafian, Peter T.
    Achanfuo-Yeboah, Joana
    Manibusan, Anthony
    Berger, Joel P.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 715 (1-3) : 41 - 45
  • [7] Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
    Chavez, Alberto O.
    Molina-Carrion, Marjorie
    Abdul-Ghani, Muhammad A.
    Folli, Franco
    DeFronzo, Ralph A.
    Tripathy, Devjit
    [J]. DIABETES CARE, 2009, 32 (08) : 1542 - 1546
  • [8] High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes A 5.4-year population-based prospective study in Chinese subjects
    Chen, Cheng
    Cheung, Bernard M. Y.
    Tso, Annette W. K.
    Wang, Yudong
    Law, Lawrence S. C.
    Ong, Kwok Leung
    Wat, Nelson M. S.
    Xu, Aimin
    Lam, Karen S. L.
    [J]. DIABETES CARE, 2011, 34 (09) : 2113 - 2115
  • [9] Osteoblast-Targeted Overexpression of PPARγ Inhibited Bone Mass Gain in Male Mice and Accelerated Ovariectomy-Induced Bone Loss in Female Mice
    Cho, Sun Wook
    Yang, Jae-Yeon
    Her, Sun Ju
    Choi, Hyung Jin
    Jung, Ju Yeon
    Sun, Hyun Jin
    An, Jee Hyun
    Cho, Hwa Young
    Kim, Sang Wan
    Park, Kyong Soo
    Kim, Seong Yeon
    Baek, Wook-Young
    Kim, Jung-Eun
    Yim, Mijung
    Shin, Chan Soo
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (08) : 1939 - 1952
  • [10] Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors
    Chow, Wing Sun
    Xu, Aimin
    Woo, Yu Cho
    Tso, Annette W. K.
    Cheung, Stephen C. W.
    Fong, Carol H. Y.
    Tse, Hung Fat
    Chau, Ming Tak
    Cheung, Bernard M. Y.
    Lam, Karen S. L.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (10) : 2454 - 2459
1234567